Mark serves on the board of directors for Benson Hill, Boston Metal, Citrine Informatics, Holo, and Zapata Computing and actively manages the firm’s investments in Arable, Atom Computing, CoverCress, GreenLight Biosciences, Fortify, Pivot Bio, Planet Labs, polySpectra, Renew Financial, Unspun, and Zymergen.
Tadeu brings 40 years of metal industry leadership and technology experience to Boston Metal. As CEO of CBMM (80% market share for niobium) he grew revenue from $100M to over $2B. In his 30 years with CBMM, Tadeu led a global strategy that grew the niobium market by over 8x through a rigorous program of customer-focused application and technology development.
Tadeu is the Lead Independent Director at Ivanhoe Mines, a board member at SBSHSL Hospital in Brazil, and an invited lecturer at the Department of Material Science and Engineering at the MIT.